Athos Capital’s M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 MBAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-66,666
Closed -$648K 178
2021
Q2
$648K Buy
+66,666
New +$55.8K 0.13% 115

Other funds holding MBAC.WS

Athos Capital's MBAC.WS Position: Q3 2021 in Review

Athos Capital sold out of M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (MBAC.WS) in Q3 2021, closing a stake of 66,666 shares — an estimated $648K sold.

Athos Capital first reported a position in MBAC.WS in Q2 2021 and held it in 1 quarter. The position peaked at $648K in Q2 2021. 45 funds tracked by Wall St. Rank hold MBAC.WS as of Q3 2021.

  • Athos Capital reported no remaining M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q3 2021 after selling out during the quarter.
  • Athos Capital sold 66,666 M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q3 2021, an estimated $648K.
  • Athos Capital first reported a position in M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q2 2021 and held it in 1 quarter.
  • Athos Capital's M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $648K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q3 2021.

Based on Athos Capital's 13F filing for Q3 2021, filed 12 Nov 2021.